Literature DB >> 17200480

Pexelizumab does not "complement" percutaneous coronary intervention in patients with ST-elevation myocardial infarction.

John W Eikelboom, Martin O'Donnell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17200480     DOI： 10.1001/jama.297.1.91

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Role of the complement components C5 and C3a in a mouse model of myocardial ischemia and reperfusion injury.

Authors:  Marc N Busche; Gregory L Stahl
Journal:  Ger Med Sci       Date:  2010-09-08

2.  B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction.

Authors:  Yasmine Zouggari; Hafid Ait-Oufella; Philippe Bonnin; Tabassome Simon; Andrew P Sage; Coralie Guérin; José Vilar; Giuseppina Caligiuri; Dimitrios Tsiantoulas; Ludivine Laurans; Edouard Dumeau; Salma Kotti; Patrick Bruneval; Israel F Charo; Christoph J Binder; Nicolas Danchin; Alain Tedgui; Thomas F Tedder; Jean-Sébastien Silvestre; Ziad Mallat
Journal:  Nat Med       Date:  2013-09-15       Impact factor: 53.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.